| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
TLC VISION CORPORATION | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
CONSOLIDATING STATEMENTS OF OPERATIONS (UNAUDITED) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(In thousands, except per share amounts) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended June 30, 2008 | | | | | | | | | | Three Months Ended June 30, 2007 | | | | | | | | |
| | | | | | | | |
| | Results Before AMD | | | | | | | | | | | | | | Results Before AMD | | | | | | | | | | | | | | | | |
| | Segment | | AMD Segment | | Total TLCVision | | | | | | Segment | | | | | | AMD Segment | | Total TLCVision |
| | | | | | | | | | | | | | | | | | | | | | |
Revenues: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Refractive centers | | $ | 39,057 | | | $ | — | | | $ | 39,057 | | | | | | | | | | | $ | 47,006 | | | | | | | $ | — | | | | | | | $ | 47,006 | |
Doctor services | | | 25,528 | | | | - | | | | 25,528 | | | | | | | 24,861 | | | - | | | | | | | | | | | | 24,861 | |
Eye care | | | 9,512 | | | | - | | | | 9,512 | | | | | | | 8,214 | | | - | | | | | | | | | | | | 8,214 | |
| | | | | | | | | | | | | | | | | | | | | | |
Total revenues | | | 74,097 | | | | - | | | | 74,097 | | | | | | | 80,081 | | | - | | | | | | | | | | | | 80,081 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Cost of revenues (excluding amortization): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Refractive centers | | | 29,409 | | | | - | | | | 29,409 | | | | | | | 32,705 | | | - | | | | | | | | | | | | 32,705 | |
Doctor services | | | 18,680 | | | | - | | | | 18,680 | | | | | | | 17,659 | | | - | | | | | | | | | | | | 17,659 | |
Eye care | | | 4,691 | | | | - | | | | 4,691 | | | | | | | 3,959 | | | - | | | | | | | | | | | | 3,959 | |
| | | | | | | | | | | | | | | | | | | | | | |
Total cost of revenues (excluding | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
amortization) | | | 52,780 | | | | - | | | | 52,780 | | | | | | | 54,323 | | | - | | | | | | | | | | | | 54,323 | |
| | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Gross profit | | | 21,317 | | | | - | | | | 21,317 | | | | | | | 25,758 | | | - | | | | | | | | | | | | 25,758 | |
| | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
General and administrative | | | 6,986 | | | | - | | | | 6,986 | | | | | | | 8,940 | | | - | | | | | | | | | | | | 8,940 | |
Marketing and sales | | | 10,209 | | | | - | | | | 10,209 | | | | | | | 10,686 | | | - | | | | | | | | | | | | 10,686 | |
Amortization of intangibles | | | 803 | | | | - | | | | 803 | | | | | | | 918 | | | - | | | | | | | | | | | | 918 | |
Other (income) expense, net | | | (359 | ) | | | — | | | | (359 | ) | | | | | | | 96 | | | | | | | | — | | | | | | | | | | | | 96 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total operating expenses | | | 17,639 | | | | - | | | | 17,639 | | | | | | | 20,640 | | | - | | | | | | | | | | | | 20,640 | |
| | | | | | | | | | | | | | | | | | | | | | |
Operating income | | | 3,678 | | | | - | | | | 3,678 | | | | | | | 5,118 | | | - | | | | | | | | | | | | 5,118 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Gain on sale of OccuLogix, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
stock | | | - | | | | - | | | | - | | | | | | | | - | | | | | | | 933 | | | | | | | 933 | |
Interest income | | | 216 | | | | - | | | | 216 | | | | | | | 579 | | | - | | | | | | | | | | | | 579 | |
Interest expense | | | (2,414 | ) | | | - | | | | (2,414 | ) | | | | | | (689) | | | - | | | | | | | | | | | | (689 | ) |
Minority interest expense | | | (3,076 | ) | | | - | | | | (3,076 | ) | | | | | | (2,643) | | | - | | | | | | | | | | | | (2,643 | ) |
(Loss) earnings from equity | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
investments | | | (319 | ) | | | - | | | | (319 | ) | | | | | | 499 | | (1,614) | | | | | | | (1,115 | ) |
| | | | | | | | | | | | | | | | | | | | | | |
(Loss) income from continuing | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
operations before income taxes | | | (1,915 | ) | | | - | | | | (1,915 | ) | | | | | | 2,864 | | (681) | | | | | | | 2,183 | |
Income tax expense | | | (285 | ) | | | - | | | | (285 | ) | | | | | | (1,653) | | | - | | | | | | | | | | | | (1,653 | ) |
| | | | | | | | | | | | | | | | | | | | | | |
(Loss) income from continuing | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
operations | | | (2,200 | ) | | | - | | | | (2,200 | ) | | | | | | 1,211 | | (681) | | | | | | | 530 | |
Income from discontinued | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
operations, net of tax | | | - | | | | - | | | | - | | | | | | | 346 | | | - | | | | | | | | | | | | 346 | |
| | | | | | | | | | | - | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net (loss) income | | $ | (2,200 | ) | | $ | — | | | $ | (2,200 | ) | | | | | | | | | | $ | 1,557 | | | | | | | $ | (681 | ) | | | | | | $ | 876 | |
| | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(Loss) earnings per share — diluted | | $ | (0.04 | ) | | $ | — | | | $ | (0.04 | ) | | | | | | | | | | $ | 0.02 | | | | | | | $ | (0.01 | ) | | | | | | $ | 0.01 | |
| | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Weighted average number of common | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
shares outstanding — diluted | | | 50,292 | | | | 50,292 | | | | 50,292 | | | | | | | 68,581 | | 68,581 | | | | | | | 68,581 | |
Note: The AMD segment includes the Company’s interest in OccuLogix, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
TLC VISION CORPORATION | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
CONSOLIDATING STATEMENTS OF OPERATIONS (UNAUDITED) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(In thousands, except per share amounts) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Six Months Ended June 30, 2008 | | | | | | | | | | Six Months Ended June 30, 2007 | | | | | | | | |
| | | | | | | | |
| | Results Before AMD | | | | | | | | | | | | | | Results Before AMD | | | | | | | | | | | | | | | | |
| | Segment | | AMD Segment | | Total TLCVision | | | | | | Segment | | | | | | AMD Segment | | Total TLCVision |
| | | | | | | | | | | | | | | | | | | | | | |
Revenues: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Refractive centers | | $ | 98,024 | | | $ | — | | | $ | 98,024 | | | | | | | | | | | $ | 98,790 | | | | | | | $ | — | | | | | | | $ | 98,790 | |
Doctor services | | | 50,591 | | | | - | | | | 50,591 | | | | | | | 49,851 | | | - | | | | | | | | | | | | 49,851 | |
Eye care | | | 15,837 | | | | - | | | | 15,837 | | | | | | | 13,786 | | | - | | | | | | | | | | | | 13,786 | |
| | | | | | | | | | | | | | | | | | | | | | |
Total revenues | | | 164,452 | | | | - | | | | 164,452 | | | | | | | 162,427 | | | - | | | | | | | | | | | | 162,427 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Cost of revenues (excluding amortization): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Refractive centers | | | 66,766 | | | | - | | | | 66,766 | | | | | | | 66,941 | | | - | | | | | | | | | | | | 66,941 | |
Doctor services | | | 36,821 | | | | - | | | | 36,821 | | | | | | | 35,460 | | | - | | | | | | | | | | | | 35,460 | |
Eye care | | | 7,513 | | | | - | | | | 7,513 | | | | | | | 6,434 | | | - | | | | | | | | | | | | 6,434 | |
| | | | | | | | | | | | | | | | | | | | | | |
Total cost of revenues (excluding | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
amortization) | | | 111,100 | | | | - | | | | 111,100 | | | | | | | 108,835 | | | - | | | | | | | | | | | | 108,835 | |
| | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Gross profit | | | 53,352 | | | | - | | | | 53,352 | | | | | | | 53,592 | | | - | | | | | | | | | | | | 53,592 | |
| | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
General and administrative | | | 15,353 | | | | - | | | | 15,353 | | | | | | | 18,857 | | | - | | | | | | | | | | | | 18,857 | |
Marketing and sales | | | 21,860 | | | | - | | | | 21,860 | | | | | | | 19,121 | | | - | | | | | | | | | | | | 19,121 | |
Amortization of intangibles | | | 1,633 | | | | - | | | | 1,633 | | | | | | | 1,702 | | | - | | | | | | | | | | | | 1,702 | |
Other (income) expense, net | | | (556 | ) | | | - | | | | (556 | ) | | | | | | 534 | | | - | | | | | | | | | | | | 534 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total operating expense | | | 38,290 | | | | - | | | | 38,290 | | | | | | | 40,214 | | | - | | | | | | | | | | | | 40,214 | |
| | | | | | | | | | | | | | | | | | | | | | |
Operating income | | | 15,062 | | | | - | | | | 15,062 | | | | | | | 13,378 | | | - | | | | | | | | | | | | 13,378 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Gain on sale of OccuLogix, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
stock | | | - | | | | - | | | | - | | | | | | | | - | | | | | | | 933 | | | | | | | 933 | |
Interest income | | | 426 | | | | - | | | | 426 | | | | | | | 1,147 | | | - | | | | | | | | | | | | 1,147 | |
Interest expense | | | (4,890 | ) | | | - | | | | (4,890 | ) | | | | | | (1,129) | | | - | | | | | | | | | | | | (1,129 | ) |
Minority interest expense | | | (5,892 | ) | | | - | | | | (5,892 | ) | | | | | | (5,091) | | | - | | | | | | | | | | | | (5,091 | ) |
(Loss) earnings from equity | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
investments | | | (102 | ) | | | - | | | | (102 | ) | | | | | | 1,310 | | (4,131) | | | | | | | (2,821 | ) |
| | | | | | | | | | | | | | | | | | | | | | |
Income (loss) from continuing | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
operations before income taxes | | | 4,604 | | | | - | | | | 4,604 | | | | | | | 9,615 | | (3,198) | | | | | | | 6,417 | |
Income tax expense | | | (732 | ) | | | - | | | | (732 | ) | | | | | | (2,604) | | | - | | | | | | | | | | | | (2,604 | ) |
| | | | | | | | | | | | | | | | | | | | | | |
Income (loss) from continuing | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
operations | | | 3,872 | | | | - | | | | 3,872 | | | | | | | 7,011 | | (3,198) | | | | | | | 3,813 | |
Income from discontinued | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
operations, net of tax | | | - | | | | - | | | | - | | | | | | | 541 | | | - | | | | | | | | | | | | 541 | |
| | | | | | | | | | | - | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net income (loss) | | $ | 3,872 | | | $ | — | | | $ | 3,872 | | | | | | | | | | | $ | 7,552 | | | | | | | $ | (3,198 | ) | | | | | | $ | 4,354 | |
| | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Earnings (loss) per share — diluted | | $ | 0.08 | | | $ | — | | | $ | 0.08 | | | | | | | | | | | $ | 0.11 | | | | | | | $ | (0.05 | ) | | | | | | $ | 0.06 | |
| | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Weighted average number of common | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
shares outstanding — diluted | | | 50,293 | | | | 50,293 | | | | 50,293 | | | | | | | 69,104 | | 69,104 | | | | | | | 69,104 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Note: The AMD segment includes the Company’s interest in OccuLogix, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
TLC VISION CORPORATION | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
CONSOLIDATING BALANCE SHEETS | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(In thousands) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | June 30, 2008 | | | | | | | | | | | | | | | | | | December 31, 2007 | | | | | | | | |
| | | | | | | | | | | - | | | | | | | | | | | | | | | | | |
| | Results Before AMD | | | | | | | | | | | | | | Results Before AMD | | | | | | | | | | | | | | | | |
| | Segment | | AMD Segment | | Total TLCVision | | | | | | Segment (Unaudited) | | AMD Segment (Unaudited) | | Total TLCVision |
| | | | | | | | | | | | | | | | | | | | | | |
ASSETS | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Current assets | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Cash and cash equivalents | | $ | 14,061 | | | $ | — | | | $ | 14,061 | | | | | | | | | | | $ | 12,925 | | | | | | | $ | — | | | | | | | $ | 12,925 | |
Accounts receivable, net | | | 18,655 | | | | - | | | | 18,655 | | | | | | | 18,076 | | | - | | | | | | | | | | | | 18,076 | |
Prepaid expenses, inventory and | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
other | | | 14,771 | | | | - | | | | 14,771 | | | | | | | 14,882 | | | - | | | | | | | | | | | | 14,882 | |
| | | | | | | | | | | | | | | | | | | | | | |
Total current assets | | | 47,487 | | | | - | | | | 47,487 | | | | | | | 45,883 | | | - | | | | | | | | | | | | 45,883 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Restricted cash | | | 208 | | | | - | | | | 208 | | | | | | | 1,101 | | | - | | | | | | | | | | | | 1,101 | |
Investments and other assets | | | 17,711 | | | | - | | | | 17,711 | | | | | | | 17,524 | | | - | | | | | | | | | | | | 17,524 | |
Goodwill | | | 101,895 | | | | - | | | | 101,895 | | | | | | | 94,346 | | | - | | | | | | | | | | | | 94,346 | |
Other intangible assets, net | | | 15,474 | | | | - | | | | 15,474 | | | | | | | 17,020 | | | - | | | | | | | | | | | | 17,020 | |
Fixed assets, net | | | 57,505 | | | | - | | | | 57,505 | | | | | | | 61,936 | | | - | | | | | | | | | | | | 61,936 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total assets | | $ | 240,280 | | | $ | — | | | $ | 240,280 | | | | | | | | | | | $ | 237,810 | | | | | | | $ | — | | | | | | | $ | 237,810 | |
| | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
LIABILITIES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Current liabilities | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Accounts payable | | $ | 23,427 | | | $ | — | | | $ | 23,427 | | | | | | | | | | | $ | 17,177 | | | | | | | $ | — | | | | | | | $ | 17,177 | |
Accrued liabilities | | | 22,270 | | | | - | | | | 22,270 | | | | | | | 28,115 | | | - | | | | | | | | | | | | 28,115 | |
Current maturities of long-term debt | | | 7,716 | | | | - | | | | 7,716 | | | | | | | 11,732 | | | - | | | | | | | | | | | | 11,732 | |
| | | | | | | | | | | | | | | | | | | | | | |
Total current liabilities | | | 53,413 | | | | - | | | | 53,413 | | | | | | | 57,024 | | | - | | | | | | | | | | | | 57,024 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Long-term debt, less current | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
maturities | | | 94,524 | | | | - | | | | 94,524 | | | | | | | 98,417 | | | - | | | | | | | | | | | | 98,417 | |
Other long-term liabilities | | | 9,878 | | | | - | | | | 9,878 | | | | | | | 5,023 | | | - | | | | | | | | | | | | 5,023 | |
Minority interests | | | 15,941 | | | | - | | | | 15,941 | | | | | | | 15,224 | | | - | | | | | | | | | | | | 15,224 | |
| | | | | | | | | | | | | | | | | | | | | | |
Total liabilities | | | 173,756 | | | | - | | | | 173,756 | | | | | | | 175,688 | | | - | | | | | | | | | | | | 175,688 | |
| | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
STOCKHOLDERS’ EQUITY | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Common stock | | | 310,049 | | | | 28,501 | | | | 338,550 | | | | | | | 308,972 | | 28,501 | | | | | | | 337,473 | |
Option and warrant equity | | | 745 | | | | - | | | | 745 | | | | | | | 837 | | | - | | | | | | | | | | | | 837 | |
Other comprehensive income | | | (1,239 | ) | | | - | | | | (1,239 | ) | | | | | | (784) | | | - | | | | | | | | | | | | (784 | ) |
Accumulated deficit | | | (243,031 | ) | | | (28,501 | ) | | | (271,532 | ) | | | | | | (246,903) | | (28,501) | | (275,404) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total stockholders’ equity | | | 66,524 | | | | - | | | | 66,524 | | | | | | | 62,122 | | | - | | | | | | | | | | | | 62,122 | |
| | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total liabilities and stockholders’ equity | | $ | 240,280 | | | $ | — | | | $ | 240,280 | | | | | | | | | | | $ | 237,810 | | | | | | | $ | — | | | | | | | $ | 237,810 | |
| | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Note: The AMD segment includes the Company’s interest in OccuLogix, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
TLC VISION CORPORATION | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
CONSOLIDATING STATEMENTS OF CASH FLOWS (UNAUDITED) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(In thousands, except per share amounts) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Six Months Ended June 30, 2008 | | | | | | | | | | Six Months Ended June 30, 2007 | | | | | | | | |
| | | | | | | | |
| | Results Before AMD | | | | | | | | | | | | | | Results Before AMD | | | | | | | | | | | | | | | | |
| | Segment | | AMD Segment | | Total TLCVision | | | | | | Segment | | | | | | AMD Segment | | Total TLCVision |
| | | | | | | | | | | | | | | | | | | | | | |
OPERATING ACTIVITIES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net income (loss) | | $ | 3,872 | | | $ | — | | | $ | 3,872 | | | | | | | | | | | $ | 7,552 | | | | | | | $ | (3,198 | ) | | | | | | $ | 4,354 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Depreciation and amortization | | | 9,877 | | | | - | | | | 9,877 | | | | | | | 9,134 | | | - | | | | | | | | | | | | 9,134 | |
Deferred taxes | | | - | | | | - | | | | - | | | | | | | 1,939 | | | - | | | | | | | | | | | | 1,939 | |
Minority interests | | | 5,892 | | | | - | | | | 5,892 | | | | | | | 5,300 | | | - | | | | | | | | | | | | 5,300 | |
Loss from equity investments | | | 102 | | | | - | | | | 102 | | | | | | | (1,310) | | 4,131 | | | | | | | 2,821 | |
Gain on sales and disposals of | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
fixed assets | | | (289 | ) | | | - | | | | (289 | ) | | | | | | (81) | | | - | | | | | | | | | | | | (81 | ) |
Gain on sale of Occulogix, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
stock | | | - | | | | - | | | | - | | | | | | | | - | | | | | | | (933) | �� | | | | | | (933 | ) |
Gain on sale of businesses | | | (145 | ) | | | — | | | | (145 | ) | | | | | | | — | | | | | | | | — | | | | | | | | | | | | — | |
Non-cash compensation expense | | | 711 | | | | - | | | | 711 | | | | | | | 731 | | | - | | | | | | | | | | | | 731 | |
Other | | | 354 | | | | - | | | | 354 | | | | | | | 117 | | | - | | | | | | | | | | | | 117 | |
Changes in operating assets and liabilities, net of acquisitions | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
and dispositions: | | | 2,173 | | | | - | | | | 2,173 | | | | | | | (1,681) | | | - | | | | | | | | | | | | (1,681 | ) |
| | | | | | | | | | | | | | | | | | | | | | |
Cash provided by operating | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
activities | | | 22,547 | | | | - | | | | 22,547 | | | | | | | 21,701 | | | - | | | | | | | | | | | | 21,701 | |
| | | | | | | | | | | | | | | | | | | | | | |
| | | — | | | | | | | | | | | | | | | | — | | | | | | | | | | | | | | | | | | | | | |
INVESTING ACTIVITIES | | | — | | | | | | | | | | | | | | | | — | | | | | | | | | | | | | | | | | | | | | |
Purchases of fixed assets | | | (1,957 | ) | | | - | | | | (1,957 | ) | | | | | | (7,281) | | | - | | | | | | | | | | | | (7,281 | ) |
Proceeds from sales of fixed assets | | | 550 | | | | - | | | | 550 | | | | | | | 268 | | | - | | | | | | | | | | | | 268 | |
Proceeds from sale of Occulogix, | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Inc. stock, net | | | - | | | | - | | | | - | | | | | | | 2,000 | | | - | | | | | | | | | | | | 2,000 | |
Distributions and loan payments | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
received from equity investments | | | 945 | | | | - | | | | 945 | | | | | | | 1,857 | | | - | | | | | | | | | | | | 1,857 | |
Acquisitions and equity investments | | | (7,533 | ) | | | - | | | | (7,533 | ) | | | | | | (3,889) | | | - | | | | | | | | | | | | (3,889 | ) |
Divestitures of business | | | 1,179 | | | | — | | | | 1,179 | | | | | | | | — | | | | | | | | — | | | | | | | | | | | | — | |
Proceeds from sales of short-term | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
investments | | | - | | | | - | | | | - | | | | | | | 17,375 | | | - | | | | | | | | | | | | 17,375 | |
Purchases of short-term investments | | | - | | | | - | | | | - | | | | | | | (5,800) | | | - | | | | | | | | | | | | (5,800 | ) |
Other | | | (28 | ) | | | — | | | | (28 | ) | | | | | | | 33 | | | | | | | | — | | | | | | | | | | | | 33 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Cash (used in) provided by | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
investing activities | | | (6,844 | ) | | | - | | | | (6,844 | ) | | | | | | 4,563 | | | - | | | | | | | | | | | | 4,563 | |
| | | | | | | | | | | | | | | | | | | | | | |
| | | — | | | | | | | | | | | | | | | | — | | | | | | | | | | | | | | | | | | | | | |
FINANCING ACTIVITIES | | | — | | | | | | | | | | | | | | | | — | | | | | | | | | | | | | | | | | | | | | |
Restricted cash movement | | | 893 | | | | — | | | | 893 | | | | | | | | — | | | | | | | | — | | | | | | | | | | | | — | |
Principal payments of debt | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
financing and capital leases | | | (17,411 | ) | | | - | | | | (17,411 | ) | | | | | | (3,497) | | | - | | | | | | | | | | | | (3,497 | ) |
Proceeds from debt financing | | | 7,385 | | | | - | | | | 7,385 | | | | | | | 85,317 | | | - | | | | | | | | | | | | 85,317 | |
Capitalized debt costs | | | (534 | ) | | | - | | | | (534 | ) | | | | | | (1,631) | | | - | | | | | | | | | | | | (1,631 | ) |
Distributions to minority interests | | | (5,175 | ) | | | - | | | | (5,175 | ) | | | | | | (4,560) | | | - | | | | | | | | | | | | (4,560 | ) |
Purchases of treasury stock | | | - | | | | - | | | | - | | | | | | | (115,748) | | | - | | | | | | | (115,748) |
Proceeds from issuances of common | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
stock | | | 275 | | | | - | | | | 275 | | | | | | | 2,154 | | | - | | | | | | | | | | | | 2,154 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Cash used in financing activities | | | (14,567 | ) | | | - | | | | (14,567 | ) | | | | | | (37,965) | | | - | | | | | | | | | | | | (37,965 | ) |
| | | | | | | | | | | | | | | | | | | | | | |
` | | | — | | | | | | | | | | | | | | | | — | | | | | | | | | | | | | | | | | | | | | |
Net increase in cash and cash | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
equivalents during the period | | | 1,136 | | | | - | | | | 1,136 | | | | | | | (11,701) | | | - | | | | | | | | | | | | (11,701 | ) |
Cash and cash equivalents, | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
beginning of period | | | 12,925 | | | | - | | | | 12,925 | | | | | | | 28,917 | | | - | | | | | | | | | | | | 28,917 | |
| | | | | | | | | | | | | | | | | | | | | | |
Cash and cash equivalents, end of period | | $ | 14,061 | | | $ | — | | | $ | 14,061 | | | | | | | | | | | $ | 17,216 | | | | | | | $ | — | | | | | | | $ | 17,216 | |
| | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating cash flow per diluted share | | $ | 0.45 | | | $ | — | | | $ | 0.45 | | | | | | | | | | | $ | 0.31 | | | | | | | $ | — | | | | | | | $ | 0.31 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Note: The AMD segment includes the Company’s interest in OccuLogix, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |